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A naturally occurring staphylococcal a-toxin fragment with an apparent membrane-binding capacity but 
without toxic activities is shown to be derived from the C-terminal half of the intact polypeptide chain by 
cleavage between position 134 and 135 in the parent molecule. The resulting N-terminus is slightly ragged 
with a fragment start not only at position 135 but also at the adjacent position 136. Another naturally occur- 
ring fragment starts at position 9, derived from an original cleavage between position 8 and 9 in the parent 
molecule. Analysis of non-purified fragment mixtures confirmed these positions and established that only 
one further region, at positions 71-72, is partly sensitive to proteolysis under natural conditions. Trypsin 
treatment has limited effects on the native toxin molecule, giving essentially only two initial cleavages with 
resultant large fragments. One of these cleavages is at the peptide bond between position 13 1 and 132, thus 
only three residues away from the position of the major naturally occurring cleavage. The other bond sensi- 
tive to trypsin is between position 8 and 9, thus identically positioned to the cleavage occurring naturally. 
Together, all the cleavages define a region in a central segment of the polypeptide chain that has all the 
properties of an inter-domain segment. The C-terminal half appears to constitute a membrane-binding do- 
main, and the N-terminal half a structure needed for full biological activity, functionally subdividing the 
parent polypeptide chain. 
Staphyloccocal a-toxin; Native fragment; Membrane binding; Tryptic cleavage; 
Electroblotting; Amino acid sequence analysis 
1. INTRODUCTION 
Different clinical isolates of Staphylococcus 
aureus secrete various membrane damaging toxins, 
of which the a-toxin is considered to be the major 
virulence factor [ 11. a-Toxin is a single polypeptide 
(Mr 33000) with lethal, dermonecrotic, cytotoxic 
and hemolytic properties, all probably dependent 
on the membrane damaging primary action of the 
toxin [2,3]. 
At high concentrations, a-toxin forms hex- 
americ circular structures on artificial and natural 
membranes [4]. It has been postulated that hex- 
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Stockholm, Sweden The fragment lacks the lethal and cytotoxic ac- 
americ a-toxin forms transmembrane pores [5], 
and in rabbit red blood cell membranes, part of the 
a-toxin molecule has been suggested to be embed- 
ded within the hydrophobic region [6]. A model 
for the toxin assembly has been proposed [7], in 
which the monomer is suggested to consist of two 
domains linked by a hinge region; upon interaction 
with membranes the hinge region opens up expos- 
ing occluded hydrophobic surfaces. The hydro- 
philic monomer is thereby converted to an amphi- 
pathic rod that becomes a subunit of the trans- 
membrane hexameric pore 171. The a-toxin gene 
has also been cloned and the DNA and amino acid 
sequences have been reported [8]. 
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tivities but inhibits these effects of the native toxin, 
suggesting that the membrane-binding region of cy- 
toxin is contained in the fragment, but that a 
region required for the toxic effects of a-toxin is 
outside this fragment. 
In the present study, we have characterized the 
cleavage site producing this fragment and another 
naturally occurring minor fragment. Similarly, 
trypsin was found to give highly specific and 
limited cleavages of the native toxin. Amino acid 
sequence analysis of the naturally occurring 
fragments and the tryptic fragments showed that 
major cleavages are in a short segment at the center 
of the polypeptide, in an N-terminal part, and in 
between these two regions. The data support a 
model for the toxin based on the existence of two 
domains and define the domain borders. 
Moreover, the cell binding activity can be at- 
tributed to one of these domains in agreement with 
previous suggestions of separate functional parts 
]3,7,101. 
2. MATERIALS AND METHODS 
2.1. Preparation of toxin and fragments 
a-Toxin was prepared from S. aureus (strain 
Wood 46) and purified as described [ 111. 
A naturally occurring fragment (apparent M, 
18 500) was obtained from an apparently normal a- 
toxin purification (fig.1) [9]. This fragment (here 
designated NF-I) lacked the lethal and cytotoxic 
activities of the intact m-toxin. However, it was 
neutralized by polyclonal ant&-toxin and retained 
the membrane-binding site since it inhibited the ef- 
fects of native a-toxin [9]. The same purification 
also yielded small amounts of a smaller (apparent 
M, 14000) fragment (designated NF-II). 
Tryptic digestion of native a-toxin (1 mg in 
1.5 ml Tris buffered saline) was performed for 4 h 
at 37°C with 30 ,ug trypsin at pH 8.0. The reaction 
was terminated by the addition of 30 ,ug lima bean 
trypsin inhibitor. These conditions were found to 
be optimal for production of two stable fragments 
(TF-I and TF-II) according to SDS-polyacrylamide 
gel electrophoresis (fig. 1) [6,12]. 
2.2. Amino acid sequence analysis 
The four polypeptide fragments (400-500 pmol) 
purified by SDS-polyacrylamide gel elec- 
trophoresis were detected by soaking the gel in 1 M 
128 
potassium chloride, which made protein bands 
temporarily visible as clear zones against an 
opaque background (modified from [ 131 by omis- 
sion of acetic acid). Appropriate bands were excis- 
ed and electroblotted onto Polybrene-impregnated 
glass fiber filter discs using an ISCO model 1750 
electrophoretic sample concentrator in a novel ap- 
plication [14]. The filter discs with the separately 
transferred and immobilized fragments were then 
subjected to degradations in an Applied 
Biosystems 470A gas-phase sequencer. 
The non-separated preparations were trans- 
ferred to 30% acetic acid by dialysis in Spectrapor 
3 tubing (native fragments), or by Sephadex G-10 
chromatography (tryptic fragments). They were 
then degraded directly in a Beckman 890D liquid- 
phase sequencer, after application into glycine- 
precycled Polybrene, as described [ 151. 
3. RESULTS 
3.1. Characterization of the cleavages yielding the 
naturally occurring fragments 
One major naturally occurring fragment (NF-I) 
of a-toxin has an apparent M, of about 18500 
(fig.1). Sequence analysis of this fragment revealed 
that it is largely homogeneous but has a ragged 
end, starting with Leu-135 (about 80% of all 
molecules) or Ile-136 (about 20%). The results 
(table 1) prove that this fragment is derived from 
cleavages at two adjacent bonds in the center of the 
parent a-toxin molecule. The calculated it4, of a 
fragment starting at Leu-135/Ile-136 and ending at 
the original C-terminus would be 18476/18 363, 
which is in good agreement with the value 18 500 
estimated from SDS-polyacrylamide gel elec- 
trophoresis (fig.1). It may be concluded that this 
naturally occurring a-toxin fragment, which con- 
tains the binding activity, corresponds to a domain 
formed by the C-terminal half of the parent 
molecule. 
Another reproducibly obtained fragment, NF-II 
(fig.l), yielded a homogeneous N-terminal se- 
quence (table 1) which can be similarly identified 
as starting at Thr-9 in the parent molecule original- 
ly secreted [8]. In order to examine the possible ex- 
istence of still further fragments, the original 
preparation was also analyzed without fragment 
separation by application to a liquid-phase se- 
quencer. The results show the presence of the same 
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A B C D E sequence of NF-I (starting at Ile-136) could 
possibly be traced but was less than 0.1 of the 
total. Together these structures account for all 
residues observed in the degradation of the 
unseparated material. 
i 
b 
Fig. 1. SDS-polyacrylamide gel electrophoresis of the 
fragments analyzed. Lanes A and E are marker proteins 
(phosphorylase b, serum albumin, ovalbumin, carbonic 
anhydrase, trypsin inhibitor, a-lactalbumin in A; 
thyroglobulin, serum albumin, catalase, lactate 
dehydrogenase, ferritin in E). The intact a-toxin is 
separated in lane B, the naturally occurring fragments in 
lane C, and the tryptic fragments in lane D. 
two sequences as from the purified NF-I and NF-II 
fragments, thus with structures tarting at Leu-135 
and Thr-9, respectively. Relative yields of these 
two fragments in the sequencer degradations of the 
intact mixture were in a ratio of 1:0.4. (The frag- 
ment corresponding to Ala I-Lys 8 was not 
observed but was conceivably removed in the 
dialysis step prior to the application to the se- 
quencer.) In addition, a third sequence was ob- 
served, corresponding to a start at Gly-72 (NF-III), 
also in a lower yield, about 0.3. Finally, the minor 
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Thus, as summarized in fig.2, it can be conclud- 
ed that the naturally occurring fragments are de- 
rived essentially from cleavages at only three 
regions. They are at peptide bonds Gly-134- 
Leu-135 (high yield, presumably corresponding to 
stoichiometic cleavage), and at peptide bonds 
Lys-8-Thr-9 and Glu-71-Gly-72 (both in about 
half the major yield, thus together approaching the 
NF-I-stoichiometry). Even considering the minor 
cleavages, specificities are extensive, since only one 
other site was found to be partly sensitive, and this 
is the bond Leu-135Ile-136 adjacent to the major 
cleavage point. 
3.2. Characterization of the tryptic cleavage 
products 
Treatment of intact cu-toxin with trypsin pro- 
duced two (apparent M, 18000) fragments (TF-I 
and TF-II, fig.l), suggesting that accessibility to 
tryptic cleavage is highly limited in the native 
molecule. Gas-phase sequencer analysis revealed 
that fragment TF-I is a homogeneous product, 
starting at Ile-132 of the parent a-toxin (table 1). 
Thus, as shown in fig.2, trypsin cleaves the native 
toxin in the center of the molecule, at a peptide 
bond only three residues away from the cleavage 
site producing the major naturally occurring frag- 
ment NF-I with the binding activity. The 
calculated M, of TF-I is 18703, in reasonable, 
agreement with the observed value of - 18000. 
Similar analysis of TF-II revealed that it also is 
homogeneous, starting at position Thr-9 of the 
parent molecule (table 1). The apparent A4, of TF- 
II (-17000) is larger than the one calculated from 
the amino acid sequence, 13446, provided TF-II 
ends at Lys-13 1. However, this deviation is within 
the possible range of the estimates from the elec- 
trophoretic migration. Furthermore, it may be 
noticed that the apparent A4, of TF-II from elec- 
trophoresis is larger than that of NF-II (fig.1) as 
expected from the relative positions of the 
characterized cleavage sites (fig.2). 
As in the case of the preparation containing the 
naturally occurring fragments (above), a tryptic 
digest of the native molecule was also submitted to 
129 
Volume 211, number 2 FEBS LETTERS January 1987 
Table 1 
Results of gas-phase sequencer degradations of the different fragments 
that were analyzed after electroblotting 
Naturally occurring fragments 
NF-I NF-II 
Tryptic fragments 
TF-I TF-II 
1. Leu 133 Be 42 1. Thr 59 
2. Be 126 Gly 45 2. Gly 80 
3. Gly 123 Ala 34 3. Thr 53 
4. Ala 114 Asn 37 4. Thr 41 
5. Asn 99 Val 37 5. Asp 51 
6. Val 111 Ser 19 6. Be 40 
7. Ser 55 Ile 22 7. Gly 31 
8. Be 106 Gly 15 8. Ser + 
9. Gly 78 9. Asn 21 
10. Thr 13 
1. Ile 52 
2. Gly 40 
3. Gly 34 
4. Leu 37 
5. Be 30 
6. Gly 27 
7. Ala 27 
8. Asn + 
9. Val 22 
1. Thr 45 
2. Gly 38 
3. Thr 33 
4. Thr 30 
5. Asp 35 
6. Be 40 
7. Gly 25 
8. Ser 15 
9. Asn + 
Values show pmols recovered in each cycle. Samples were purified by 
SDS-polyacrylamide gel electrophoresis and transferred to glass fiber 
filter discs as described [14] 
- NF-III 
Fig.2. Schematic diagram showing the relative positions of the cleavage sites defined. The continuous line shows relative 
positions of the regions discussed in the mature a-toxin structure, drawn to scale and derived from [8]. Relevant portions 
now analyzed in the cleavage products are enlarged above the continuous line, with data from table 1. T, tryptic 
cleavage, N, native cleavage, at positions indicated by the arrows: thick arrow, major cleavage in high yield; thin arrow, 
a major cleavage; dashed arrow, a minor cleavage. Results of the sequencer degradations of the isolated fragments and 
the unseparated mixtures are indicated below. Both TF-II and NF-II suggest smaller sizes than those estimated from 
apparent electrophoretic mobilities (fig. 1). Consequently, C-terminal regions of these fragments are only tentative. The 
absolute migrations of TF-II and NF-II (fig. 1) are small in relation to that expected from the sizes concluded from the 
characterized cleavage points. However, the relative migration differences between TF-II and NF-II (fig. 1) are 
consistent with the relative size differences suggested from the cleavage points. 
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direct sequencer analysis without prior peptide 
purification, in order to judge relative ratios of all 
cleavages. The results showed essentially three ma- 
jor N-terminal sequences, starting at positions 
Ala-l, Thr-9, and Ile-132. However, the degrada- 
tion results from the tryptic digest were far from as 
conclusive as those from the preparation of the 
naturally occurring fragments (above), and also 
showed minor cleavages at several other positions 
that could not be fully interpreted in detail. Conse- 
quently, trypsin is concluded to have a stronger 
and further action on the entire polypeptide chain 
than the protease giving the naturally occurring 
fragments. Significantly, the electrophoretically 
observed tryptic fragments (fig. 1) gradually disap- 
pear on extended digestions, in agreement with the 
results from sequence analysis. In any event, the 
analysis of the unseparated digest confirms the 
results from analysis of the tryptic fragments (table 
1) and defines the regions of initial and maximal 
sensitivity to tryptic cleavage. 
4. DISCUSSION 
Based on previous characterizations of the 
naturally occurring fragment (NF-I) a hypothetical 
map of a-toxin was constructed, in which the 
binding region of u-toxin was placed in the center 
of the molecule [9]. The binding fragment was then 
thought to correspond to the N-terminal half of 
the parent molecule, based on comparison with 
two previously described biologically active tryptic 
fragments [16]. However, the sequence analysis 
now locates the N-terminus of the binding frag- 
ment at positions 135/136, indicating that this 
fragment in fact corresponds to the C-terminal 
half of the parent molecule. 
Sequence analysis of the two fragments obtained 
by tryptic digestion of a-toxin placed their N- 
terminal regions very close to or identical with 
those of the naturally occurring fragments (fig.2), 
thus confirming that native a-toxin is accessible to 
mild proteolytic digestion in the middle of the 
polypeptide chain and to a somewhat lower extent 
only at two regions in the N-terminal half. The 
cleavage region at the center of the molecule coin- 
cides with a postulated inter-domain hinge region 
[7], based on digestion with proteinase K. This is 
also one of the three high hydrophobicity regions 
of a-toxin [S]. The membrane-binding site of cy- 
toxin may be located near the N-terminus of NF-I, 
since the C-terminal CNBr-fragment has been 
shown before to be non-essential for binding [lo]. 
We have not been able to detect any separate 
biological activity in the fragments starting at 
Thr-9. However, it was inferred from the recent 
characterization of CNBr-fragments of a-toxin 
[lo] that this half of the molecule may be essential 
for adequate hexamer formation, as also implicit 
in the postulated assembly model [7]. 
In summary, the present results establish a two- 
domain structure for a-toxin. Naturally occurring 
fragments, and those from tryptic treatment give 
essentially similar cleavage patterns, with a central 
accessible region which has been defined at posi- 
tions between 131 and 135 in the native molecule. 
The results indicate that the binding region is 
situated in the C-terminal domain and that full 
biological activity also requires the N-terminal 
domain. 
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